Cigna Group $CI Shares Sold by World Investment Advisors

World Investment Advisors reduced its position in shares of Cigna Group (NYSE:CI) by 27.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 5,698 shares of the health services provider’s stock after selling 2,155 shares during the quarter. World Investment Advisors’ holdings in Cigna Group were worth $1,568,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CI. OLD National Bancorp IN boosted its holdings in shares of Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after purchasing an additional 37 shares in the last quarter. Leavell Investment Management Inc. boosted its holdings in shares of Cigna Group by 3.8% in the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock valued at $318,000 after purchasing an additional 40 shares in the last quarter. Physician Wealth Advisors Inc. boosted its holdings in shares of Cigna Group by 1.5% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock valued at $782,000 after purchasing an additional 41 shares in the last quarter. Cookson Peirce & Co. Inc. boosted its holdings in shares of Cigna Group by 0.8% in the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock valued at $1,428,000 after purchasing an additional 41 shares in the last quarter. Finally, Signet Financial Management LLC boosted its holdings in shares of Cigna Group by 0.6% in the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock valued at $2,150,000 after purchasing an additional 41 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CI has been the topic of several recent research reports. Jefferies Financial Group cut their price objective on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Piper Sandler cut their price objective on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Barclays raised their price objective on Cigna Group from $303.00 to $310.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Mizuho set a $330.00 price objective on Cigna Group in a report on Friday, May 1st. Finally, Robert W. Baird set a $337.00 price objective on Cigna Group in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.35.

Insiders Place Their Bets

In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 205,904 shares of company stock valued at $60,277,068. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Down 3.3%

Shares of CI opened at $285.25 on Friday. The company has a market capitalization of $75.46 billion, a PE ratio of 12.09, a PEG ratio of 1.00 and a beta of 0.30. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The stock’s 50-day moving average price is $274.95 and its two-hundred day moving average price is $275.97. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is presently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.